Dow Jones
32.149,63 +287,65 (+0,90%) Nasdaq
11.606,10 -24,42 (-0,21%) Nikkei 225
26.945,67 -388,12 (-1,42%) EUR/USD
1,0726 +0,0055 (+0,51%) Bitcoin EUR
25.726,48 -387,22 (-1,48%) CMC Crypto 200
602,40 +2,73 (+0,45%)
Guerbet SA (0ELV.L)
| Chiusura precedente | 18,84 |
| Aperto | 18,84 |
| Denaro | 0,00 x N/D |
| Lettera | 0,00 x N/D |
| Min-Max giorno | 18,84 - 19,34 |
| Intervallo di 52 settimane | 18,84 - 19,34 |
| Volume | |
| Media Volume | N/D |
| Capitalizzazione | 2,389M |
| Beta (5 anni mensile) | 0,68 |
| Rapporto PE (ttm) | 0,07 |
| EPS (ttm) | 2,58 |
| Prossima data utili | N/D |
| Rendimento e dividendo (forward) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | N/D |
- GlobeNewswire
Guerbet: 2022 revenue
2022 revenue Activity Annual revenue: €753.3 million, up +2.9% (-1.1% at CER1); production lags at the Raleigh site weighed on activity Profitability 2022 EBITDA margin: confirmation of the announced range of 13% to 14% (excluding extraordinary costs for the optimization of the operational structure and changes in the sales model in China) Outlook 2023 revenue: expected growth above 5% on a like-for-like basis and at CER Villepinte, February 9, 2023: Guerbet (FR0000032526 GBT), a global speciali
- GlobeNewswire
Guerbet: 2023 Strategic Priorities
2023 Strategic Priorities Diagnostic Imaging: increase EluciremTM sales and strengthen international positionsInterventional Imaging: prioritise Lipiodol sales with the development of innovative indications Artificial Intelligence: execution of the roadmap for the emergence of a major AI player dedicated to medical imaging in oncology Villepinte, 16 January 2023: Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging has announced its strategic prior
- GlobeNewswire
Guerbet: Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions
Intrasense opens its share capital to the Guerbet Group, which announces its intent to file a voluntary tender offer under the same price conditions Montpellier, France, January 11, 2023 at 6:00 PM CET Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software solutions ("Intrasense" or the "Company") announces that the Guerbet Group (FR0000032526 - GBT) has acquired a 39% stake in its share capital through a reserved share capital increase for a total amount of 8.8 million euro
